Ion Beam Applications SA
Sylviane Berger has a solid work experience in the field of quality assurance and regulatory affairs. Sylviane started their career in 1997 as a Quality Assurance Manager at International Brachytherapy, where they worked until 2008. Sylviane then joined Boston Scientific as an RA & QA Manager until 2012. From 2012 to 2016, they served as the EMEA Quality Assurance Manager at Biosense Webster. Currently, Sylviane is working at IBA, where they have held the positions of Director Customer complaints and Materio-vigilance since September 2016 and Quality Assurance Director since March 2019.
Sylviane Berger attended College St Michel from 1984 to 1988 and later pursued their education at Université libre de Bruxelles from 1988 to 1994. However, no specific degree or field of study information is provided.
This person is not in any teams
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.